This 89bio Insider Increased Their Holding By 41 percent Last Year

ETNB Stock  USD 8.99  0.15  1.64%   
About 56% of 89bio's investor base is looking to short. The analysis of the overall investor sentiment regarding 89bio Inc suggests that many traders are alarmed. The current market sentiment, together with 89bio's historical and current headlines, can help investors time the market. In addition, many technical investors use 89bio Inc stock news signals to limit their universe of possible portfolio assets.
  
Insiders were net buyers of 89bio, Inc.s stock during the past year. That is, insiders bought more...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

89bio Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards 89bio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

89bio Fundamental Analysis

We analyze 89bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 89bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 89bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Asset

Net Asset Comparative Analysis

89bio is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.

89bio Inc Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with 89bio stock to make a market-neutral strategy. Peer analysis of 89bio could also be used in its relative valuation, which is a method of valuing 89bio by comparing valuation metrics with similar companies.

Peers

89bio Related Equities

XFORX4 Pharmaceuticals   11.43   
0%
100.0%
HEPAHepion Pharmaceuticals   4.69   
0%
41.0%
PLRXPliant Therapeutics   2.00   
0%
17.0%
STOKStoke Therapeutics   1.68   
0%
14.0%
HOOKHookipa Pharma   1.61   
0%
14.0%
DAWNDay One   1.53   
0%
13.0%
MREOMereo BioPharma   1.40   
0%
12.0%
ABOSAcumen Pharmaceuticals   0.44   
0%
3.0%
AKROAkero Therapeutics   0.22   
1.0%
0%
INZYInozyme Pharma   0.37   
3.0%
0%
TGTXTG Therapeutics   0.57   
4.0%
0%
MDGLMadrigal Pharmaceuticals   0.98   
8.0%
0%
ACLXArcellx   1.12   
9.0%
0%
TERNTerns Pharmaceuticals   1.58   
13.0%
0%
VKTXViking Therapeutics   2.88   
25.0%
0%

Complementary Tools for 89bio Stock analysis

When running 89bio's price analysis, check to measure 89bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 89bio is operating at the current time. Most of 89bio's value examination focuses on studying past and present price action to predict the probability of 89bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 89bio's price. Additionally, you may evaluate how the addition of 89bio to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges